PRIA Logo™
LouisianaSB 2532026 Regular SessionSenateWALLET

PUBLIC HEALTH: Provides relative to peptides. (8/1/26)

Sponsored By: Patrick McMath (Republican)

Signed by Governor

Health and Welfare

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Fewer peptide restrictions for Louisiana patients

Beginning August 1, 2026, Louisiana licensing boards cannot bar providers with prescribing authority from providing peptides shipped from two qualifying sources. One is an FDA-registered 503B outsourcing facility that follows 21 U.S.C. 353b. The other is a 503A compounding pharmacy that follows 21 U.S.C. 353a and applicable United States Pharmacopeia–National Formulary standards. Boards also cannot bar Louisiana-licensed pharmacists in state-permitted pharmacies from preparing and dispensing peptides. Those pharmacists and pharmacies must follow 21 U.S.C. 353a and the applicable standards named above.

Sponsors & Cosponsors

Sponsor

  • Patrick McMath

    Republican • Senate

Cosponsors

  • John E. Wyble

    Republican • House

  • Kim Carver

    Republican • House

  • Michael Robert Bayham Jr.

    Republican • House

  • Stephanie H. Berault

    Republican • House

Roll Call Votes

All Roll Calls

Yes: 143 • No: 0

House vote • 5/7/2026

Read third time by title, roll called on final passage, yeas 98, nays 0. Finally passed, ordered to the Senate.

Yes: 98 • No: 0

House vote • 4/28/2026

Reported with amendments

Yes: 10 • No: 0

Senate vote • 3/23/2026

Senate floor amendments read and adopted. Read by title and passed by a vote of 35 yeas and 0 nays; ordered reengrossed and sent to the House. Motion to reconsider tabled.

Yes: 35 • No: 0

Actions Timeline

  1. Signed by the Governor. Becomes Act No. 374.

    5/22/2026Senate

  2. Effective date 8/1/2026.

    5/22/2026Senate

  3. Sent to the Governor by the Secretary of the Senate.

    5/20/2026Senate

  4. Enrolled. Signed by the President of the Senate.

    5/19/2026Senate

  5. Signed by the Speaker of the House.

    5/19/2026House

  6. Received from the House with amendments.

    5/11/2026Senate

  7. Read third time by title, roll called on final passage, yeas 98, nays 0. Finally passed, ordered to the Senate.

    5/7/2026House

  8. Scheduled for floor debate on 05/07/2026.

    5/6/2026House

  9. Read by title, amended, passed to 3rd reading.

    5/5/2026House

  10. Reported without Legislative Bureau amendments.

    4/29/2026House

  11. Reported with amendments (10-0). Referred to the Legislative Bureau.

    4/28/2026House

  12. Read by title, under the rules, referred to the Committee on Health and Welfare.

    3/25/2026House

  13. Received in the House from the Senate, read by title, lies over under the rules.

    3/24/2026House

  14. Senate floor amendments read and adopted. Read by title and passed by a vote of 35 yeas and 0 nays; ordered reengrossed and sent to the House. Motion to reconsider tabled.

    3/23/2026Senate

  15. Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage.

    3/16/2026Senate

  16. Reported with amendments.

    3/11/2026Senate

  17. Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Health and Welfare.

    3/9/2026Senate

  18. Prefiled and under the rules provisionally referred to the Committee on Health and Welfare.

    2/26/2026Senate

Bill Text

Related Bills

Back to State Legislation